LEVOLIN PLUS JR (Ambroxol (15mg) + Levosalbutamol (0.5mg) + Guaifenesin (50mg))

Levolin Plus Jr Expectorant is a formulation designed to assist in alleviating cough that is accompanied by mucus. This medication facilitates the thinning of mucus in areas such as the nasal passages, trachea, and lungs, thereby making it easier for patients to expel it through coughing. Additionally, it offers relief from symptoms such as a runny nose, sneezing, itchy sensations, and watery eyes. The administration of Levolin Plus Jr Expectorant can be done with or without food, and it is crucial that patients follow the dosage and duration of treatment as prescribed by their healthcare provider. The specific dosage may vary based on the individual’s medical condition and their response to the treatment. It is important to continue using the medication for the duration recommended by the healthcare professional to prevent the return or worsening of symptoms. Patients are advised to inform their healthcare team of any other medications they are currently taking, as there could be interactions with Levolin Plus Jr Expectorant. While this medication is generally well-tolerated, some common side effects may include nausea, diarrhea, abdominal discomfort, vomiting, muscle cramps, headaches, skin rashes, and an elevated heart rate. Most side effects are temporary and tend to diminish over time. If any side effects cause concern, it is essential to contact a doctor promptly. This medication may induce drowsiness, so individuals should refrain from operating vehicles or engaging in activities requiring full concentration until they understand how it affects them. It is advisable to avoid alcohol consumption while undergoing treatment with this medicine, as it may exacerbate feelings of drowsiness. Adequate fluid intake is also recommended during the course of this treatment. Prior to using this medicine, patients should communicate with their healthcare provider if they are pregnant, planning to become pregnant, or breastfeeding. Any existing kidney or liver issues should also be disclosed to ensure appropriate dosing.